p(MGI:Chrm4) decreases act(p(MGI:Drd1))

View Subject View Object

PubMed:24590577

M4 mAChR is also involved in the pathology of Parkinson’s disease, which is associated with the loss of dopaminergic neurons projecting to the striatum and an imbalance between cholinergic and dopaminergic systems. In the corpus striatum, M4 mAChR is closely co-localized with dopamine receptors on striatal-projecting neurons and the striatal M4 mAChR inhibits dopamine D1 receptor function. Mice lacking M4 mAChR show increased locomotor activity and enhanced dopamine D1 receptor-mediated effects[55]. Consequently, selective M4 mAChR antagonists, such as benzoxazines, have been developed for the treatment of Parkinson’s disease

Related Edges 6

• a(CHEBI:benzoxazine) decreases path(MESH:"Parkinson Disease")
• p(HGNC:CHRM4) association path(MESH:"Parkinson Disease")
• p(HGNC:CHRM4) decreases act(p(HGNC:DRD1))
• p(MGI:Chrm4) decreases bp(GO:"locomotor rhythm")
• path(MESH:"Parkinson Disease") association p(HGNC:CHRM4)
• path(MESH:"Parkinson Disease") decreases act(a(MESH:"Dopaminergic Neurons"))

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---